Addition Therapeutics is pioneering advancements in genetic medicine through its innovative approach to developing RNA-only therapeutics. The company focuses on the PRINT technology, which allows for the precise integration of genetic elements into designated safe harbor sites within the genome. This cutting-edge method aims to enhance the precision and efficacy of gene therapies.